132 related articles for article (PubMed ID: 31517774)
21. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
22. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
[TBL] [Abstract][Full Text] [Related]
23. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract][Full Text] [Related]
24. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
25. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcoma: analysis of prognostic variables in 71 cases.
Wheelock JB; Krebs HB; Schneider V; Goplerud DR
Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands.
Benito V; Lubrano A; Arencibia O; Andújar M; Alvarez E; Medina N; Falcón JM; Falcón O
Int J Gynaecol Obstet; 2009 Oct; 107(1):44-9. PubMed ID: 19555952
[TBL] [Abstract][Full Text] [Related]
28. [Clinical aspects of uterine sarcomas (author's transl)].
Stegner HE
Pathol Res Pract; 1980 Oct; 169(2):120-6. PubMed ID: 7443570
[TBL] [Abstract][Full Text] [Related]
29. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma.
Evans HL
Cancer; 1982 Nov; 50(10):2170-82. PubMed ID: 7127257
[TBL] [Abstract][Full Text] [Related]
30. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
32. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and prognostic factors of the uterine sarcomas: 20 years of experience at Cukurova University.
Khatib G; Guzel AB; Gulec UK; Gumurdulu D; Vardar MA; Altintas A
Eur J Gynaecol Oncol; 2014; 35(6):646-54. PubMed ID: 25556269
[TBL] [Abstract][Full Text] [Related]
34. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
[No Abstract] [Full Text] [Related]
35. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
36. CD146 as an adverse prognostic factor in uterine sarcoma.
Zhou Y; Huang H; Yuan LJ; Xiong Y; Huang X; Lin JX; Zheng M
Eur J Med Res; 2015 Aug; 20(1):67. PubMed ID: 26293576
[TBL] [Abstract][Full Text] [Related]
37. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
[TBL] [Abstract][Full Text] [Related]
38. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
39. Uterine sarcoma: 14 years experience in KCCC.
Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
[TBL] [Abstract][Full Text] [Related]
40. Uterine sarcomas: a clinicopathologic study.
Chiara S; Foglia G; Odicino F; Graziani A; Conte PF; Ragni N; Fulcheri E; Pescetto G
Oncology; 1988; 45(6):428-33. PubMed ID: 3186152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
